A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 39/395 (2006.01) A61K 47/48 (2006.01) A61P 35/00 (2006.01) C07K 16/30 (2006.01)
Patent
CA 2471206
The present invention relates to a method for producing patient specific anti- cancer antibodies using a novel paradigm of screening. By segregating the anti- cancer antibodies using cancer cell cytotoxicity as end point, the process makes possible the production of anti-cancer antibodies customized for the individual patient that can be used for therapeutic and diagnostic purposes.
L'invention concerne une méthode qui permet de produire des anticorps anticancéreux spécifiques du patient au moyen d'un nouveau modèle de criblage. La séparation des anticorps anticancéreux, qui utilise la cytotoxicité des cellules cancéreuses comme point final, permet de produire sur mesure des anticorps anticancéreux pour chaque patient à des fins thérapeutiques et diagnostiques.
Takahashi Miyoko
Young David S. F.
Arius Research Inc.
F.hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Individualized anti-cancer antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Individualized anti-cancer antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Individualized anti-cancer antibodies will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1712011